• OPEN AN ACCOUNT
Indian Indices
Sensex
84,874.07 -189.27
( -0.22%)
Global Indices
Nasdaq
49,481.66 483.47
(0.99%)
Dow Jones
6,965.42 42.37
(0.61%)
Hang Seng
52,499.37 666.57
(1.29%)
Nikkei 225
10,156.61 152.04
(1.52%)
Forex
USD-INR
90.21 0.17
(0.19%)
EUR-INR
105.52 0.01
(0.01%)
GBP-INR
121.54 0.38
(0.31%)
JPY-INR
0.58 0.00
(0.26%)

EQUITY - MARKET SCREENER

Cian Healthcare Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
542678
INE05BN01019
16.8648832
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
13.72
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

lancor holdings ltd
Premier Explosives secures Rs 73-cr export order
Nov 25,2025
According to the company’s exchange filing, the order is scheduled to be executed within 12 months. The firm also clarified that neither its promoters nor members of the promoter group have any interest in the awarding authority, confirming that the transaction does not fall under related-party dealings as per regulatory norms.

Premier Explosives is engaged in manufacture of high energy materials like bulk explosives, packaged explosives, detonators, detonating fuse, solid propellants, pyrogen igniters, pyro devices, etc., having applications in mining, infrastructure, defence, space, homeland security and such other areas. The company also operates and maintains solid propellant plants of defence and space establishments.

The company's consolidated net profit surged 111.5% to Rs 17.81 crore, while net sales fell 20.1% to Rs 75.58 crore in Q2 FY26 over Q2 FY25.

The counter fell 5.60% to Rs 525.35 on the BSE.